Cargando…
Perampanel in real‐world clinical care of patients with epilepsy: Interim analysis of a phase IV study
OBJECTIVE: To assess the retention rate, efficacy, safety, and dosing of perampanel administered to patients with epilepsy during routine clinical care in the retrospective phase IV, PROVE Study (NCT03208660). METHODS: Exposure, efficacy, and safety data were obtained from the medical records of pat...
Autores principales: | Wheless, James, Wechsler, Robert T., Lancman, Marcelo, Aboumatar, Sami, Patten, Anna, Malhotra, Manoj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918328/ https://www.ncbi.nlm.nih.gov/pubmed/33681651 http://dx.doi.org/10.1002/epi4.12445 |
Ejemplares similares
-
PROVE: Retrospective, non‐interventional, Phase IV study of perampanel in real‐world clinical care of patients with epilepsy
por: Wechsler, Robert T., et al.
Publicado: (2022) -
Real‐world analysis of hospitalizations in patients with epilepsy and treated with perampanel
por: Faught, Edward, et al.
Publicado: (2021) -
Assessment of the long‐term efficacy and safety of adjunctive perampanel in tonic‐clonic seizures: Analysis of four open‐label extension studies
por: Rektor, Ivan, et al.
Publicado: (2020) -
Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double‐blind, phase III studies
por: Steinhoff, Bernhard J., et al.
Publicado: (2020) -
Efficacy and safety of adjunctive perampanel in patients with focal seizures or generalized tonic‐clonic seizures: Post hoc analysis of Phase II and Phase III double‐blind and open‐label extension studies in India
por: Mehndiratta, Man M., et al.
Publicado: (2021)